[1]
Т. М. Соломенчук and О. В. Восух, “Correction of neurogumoral and psycho-emotional disorders in patients with stable coronary artery disease and arterial hypertension: adaptation possibilities of Noofen®”, FMEP, no. 1, pp. 58–68, Mar. 2018.